Immunotherapy of pediatric solid tumors: Treatments at a crossroads, with an emphasis on antibodies Review
| Authors: | Casey, D. L.; Cheung, N. K. V. |
| Review Title: | Immunotherapy of pediatric solid tumors: Treatments at a crossroads, with an emphasis on antibodies |
| Abstract: | Over the last decade, immunotherapy has rapidly changed the therapeutic landscape and prognosis for many hematologic malignancies and adult solid tumors. Despite this success, immunotherapy for pediatric solid tumors remains in the early stages of development, and significant clinical benefit has yet to be realized, with anti-GD2 for neuroblastoma being the exception. The limited neoepitope expression and paucity of T-cell infiltration into the immunosuppressive tumor microenvironment have hampered current established immunotherapies. Emerging approaches to recruit T cells, to convert phenotypically "cold" into "inflamed" tumors, and to vastly improve therapeutic indices hold exceptional promise. Here, we review these approaches, highlighting the role of the tumor microenvironment and novel antibody platforms to maximize the full clinical potential of immunotherapy in pediatric oncology. ©2020 American Association for Cancer Research. |
| Journal Title: | Cancer Immunology Research |
| Volume: | 8 |
| Issue: | 2 |
| ISSN: | 2326-6066 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-02-01 |
| Start Page: | 161 |
| End Page: | 166 |
| Language: | English |
| DOI: | 10.1158/2326-6066.Cir-19-0692 |
| PUBMED: | 32015013 |
| PROVIDER: | scopus |
| PMCID: | PMC7058412 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 March 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work